131 related articles for article (PubMed ID: 33563030)
1. Quantitative Prostate MRI Analysis Following Fluvastatin Therapy for Localized Prostate Cancer - A Pilot Study.
Avery A; Sussman M; Longo J; Menezes RJ; Hamilton RJ; der Kwast THV; Fleshner NE; Penn LZ; Ghai S
Can Assoc Radiol J; 2021 Nov; 72(4):750-758. PubMed ID: 33563030
[TBL] [Abstract][Full Text] [Related]
2. A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer.
Longo J; Hamilton RJ; Masoomian M; Khurram N; Branchard E; Mullen PJ; Elbaz M; Hersey K; Chadwick D; Ghai S; Andrews DW; Chen EX; van der Kwast TH; Fleshner NE; Penn LZ
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):630-637. PubMed ID: 32203069
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
[TBL] [Abstract][Full Text] [Related]
5. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
Rakauskas A; Shah TT; Peters M; Randeva JS; Hosking-Jervis F; Schmainda MJ; Orczyck C; Emberton M; Arya M; Moore C; Ahmed HU
Urol Oncol; 2021 Dec; 39(12):830.e1-830.e8. PubMed ID: 34049783
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI as a Biomarker of Response to Neoadjuvant Therapy for Localized Prostate Cancer-A Pilot Study.
Fennessy FM; Fedorov A; Vangel MG; Mulkern RV; Tretiakova M; Lis RT; Tempany C; Taplin ME
Acad Radiol; 2020 Oct; 27(10):1432-1439. PubMed ID: 31862185
[TBL] [Abstract][Full Text] [Related]
7. Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.
Sureka B; Elhence P; Khera PS; Choudhary GR; Pandey H; Garg PK; Yadav K; Goel A
Br J Radiol; 2019 Aug; 92(1100):20190181. PubMed ID: 31184934
[TBL] [Abstract][Full Text] [Related]
8. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
9. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
[TBL] [Abstract][Full Text] [Related]
11. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.
De Visschere PJ; Vral A; Perletti G; Pattyn E; Praet M; Magri V; Villeirs GM
Eur Radiol; 2017 May; 27(5):2095-2109. PubMed ID: 27491874
[TBL] [Abstract][Full Text] [Related]
13. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study.
McCann SM; Jiang Y; Fan X; Wang J; Antic T; Prior F; VanderWeele D; Oto A
AJR Am J Roentgenol; 2016 Mar; 206(3):559-65. PubMed ID: 26901012
[TBL] [Abstract][Full Text] [Related]
19. The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI.
Fedorov A; Penzkofer T; Hirsch MS; Flood TA; Vangel MG; Masry P; Tempany CM; Mulkern RV; Fennessy FM
Acad Radiol; 2015 May; 22(5):548-55. PubMed ID: 25683501
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men.
Kido A; Tamada T; Kanomata N; Yamamoto A; Miyaji Y; Nagai A; Sone T
Jpn J Radiol; 2019 Feb; 37(2):154-164. PubMed ID: 30600483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
